Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
101.6 EUR
1.2%
Updated:
Apr 30, 2024
Gerresheimer AG
Operating Income
|
Gerresheimer AG
Operating Income Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Operating Income
€214.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
E
|
Evotec SE
XETRA:EVT
|
Operating Income
€1.7m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Operating Income
€171.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Operating Income?
Operating Income
214.3m
EUR
214.3m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Operating Income amounts to 214.3m EUR.
What is Gerresheimer AG's Operating Income growth rate?
Operating Income CAGR 10Y
5%
5%
Over the last year, the Operating Income growth was 20%. The average annual Operating Income growth rates for Gerresheimer AG have been 9% over the past three years , 8% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
